NCT04965987 2025-07-11
Oxaloacetate in Myasthenia Gravis
University of Kansas Medical Center
Phase 1 Withdrawn
Clinical Trials
4 trialsNCT04982289 2022-02-11
Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 2 Withdrawn
NCT03900585 2021-03-10
Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis Patients
Rigshospitalet, Denmark
Phase NA Withdrawn
NCT03165435 2018-05-30
A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis
CuraVac
Phase 2/3 Withdrawn